molsidomine has been researched along with Diabetes Mellitus in 4 studies
Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Witte, MB | 1 |
| Kiyama, T | 1 |
| Barbul, A | 1 |
| Gugliucci, A | 1 |
| Chandra, A | 1 |
| Srivastava, S | 1 |
| Petrash, JM | 1 |
| Bhatnagar, A | 1 |
| Srivastava, SK | 1 |
| Bridges, CC | 1 |
| Ola, MS | 1 |
| Prasad, PD | 1 |
| El-Sherbeny, A | 1 |
| Ganapathy, V | 1 |
| Smith, SB | 1 |
4 other studies available for molsidomine and Diabetes Mellitus
| Article | Year |
|---|---|
Nitric oxide enhances experimental wound healing in diabetes.
Topics: Animals; Blotting, Northern; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimen | 2002 |
Human plasminogen is highly susceptible to peroxynitrite inactivation.
Topics: Antithrombin III; Chromogenic Compounds; Data Interpretation, Statistical; Diabetes Mellitus; Drug C | 2003 |
Active site modification of aldose reductase by nitric oxide donors.
Topics: Aldehyde Reductase; Binding Sites; Borohydrides; Catalysis; Diabetes Complications; Diabetes Mellitu | 1997 |
Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells.
Topics: Animals; Antioxidants; Ascorbic Acid; Carrier Proteins; Cell Line; Diabetes Mellitus; Dose-Response | 2001 |